Literature DB >> 12890844

Bisphosphonate-induced osteopetrosis.

Michael P Whyte1, Deborah Wenkert, Karen L Clements, William H McAlister, Steven Mumm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12890844     DOI： 10.1056/NEJMoa023110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  86 in total

1.  Comment on Xue et al.: Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion: an experimental study in a porcine model.

Authors:  Saurabh Singh; Vikram Singh; Anil Joshi
Journal:  Int Orthop       Date:  2010-05-09       Impact factor: 3.075

2.  Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Authors:  Anita P Price; Sara J Abramson; Sinchun Hwang; Alexander Chou; Roger Bartolotta; Paul Meyers; Douglas S Katz
Journal:  Pediatr Radiol       Date:  2010-10-30

Review 3.  Subtrochanteric femoral insufficiency fractures related to the use of long-term bisphosphonates: a pictorial review.

Authors:  Nanda Venkatanarasimha; Gemma Miles; Priya Suresh
Journal:  Emerg Radiol       Date:  2010-07-20

4.  Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta.

Authors:  Eva Aström; Håkan Jorulf; Stefan Söderhäll
Journal:  Arch Dis Child       Date:  2006-11-17       Impact factor: 3.791

5.  Osteoclasts: what do they do and how do they do it?

Authors:  Steven L Teitelbaum
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 6.  Unmet needs in fracture prevention: new European guidelines for the investigation and registration of therapeutic agents.

Authors:  E Seeman
Journal:  Osteoporos Int       Date:  2007-02-17       Impact factor: 4.507

7.  Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates.

Authors:  N Nicolaou; Y Agrawal; M Padman; J A Fernandes; M J Bell
Journal:  J Child Orthop       Date:  2012-01-17       Impact factor: 1.548

Review 8.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Authors:  Beatrice J Edwards; Andrew D Bunta; Joseph Lane; Clarita Odvina; D Sudhaker Rao; Dennis W Raisch; June M McKoy; Imran Omar; Steven M Belknap; Vishvas Garg; Allison J Hahr; Athena T Samaras; Matthew J Fisher; Dennis P West; Craig B Langman; Paula H Stern
Journal:  J Bone Joint Surg Am       Date:  2013-02-20       Impact factor: 5.284

9.  Serum creatine kinase isoenzymes in children with osteogenesis imperfecta.

Authors:  P D'Eufemia; R Finocchiaro; A Zambrano; V Lodato; L Celli; S Finocchiaro; P Persiani; A Turchetti; M Celli
Journal:  Osteoporos Int       Date:  2016-08-25       Impact factor: 4.507

10.  Bone: Use of bisphosphonates in children-proceed with caution.

Authors:  Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.